Management & Scientific Consulting — Lisbon

We turn raw potential into refined results.

Prime matter is the base substance everything is made from. We refine it — pairing deep scientific expertise with proven operational and strategic execution. Two partners, evidence-led work, outcomes you can measure.

Evaluation · THCS / EU
Chaired a €34M+ transnational call
Operations · Oxford
4 departments → 1 managed function
Process · national scale
90 days → 48 hours
How we work

Two partners. No layers.

You work directly with the people doing the work — not an account manager and a slide deck. Every engagement is led personally by one or both partners, scoped to what we can genuinely deliver, and grounded in data rather than generalities.

We don't claim to do everything. We do a focused set of things well, and we'll tell you plainly when a problem sits outside that set.

Many engagements are governed by NDAs. Discretion is part of the service.

What we do

A focused set of services.

Each service is owned by the partner who delivers it — so you always know exactly who is doing the work.

Led by Miguel Galaz

Operations & Strategy

Diagnosing where organisations lose time, money, and clarity — then redesigning the processes that fix it.

  • Operations consulting
  • Business & process improvement
  • Customer journey design
  • Project management
  • Funding & grant applications (national & European)
Led by Rosa Direito

Science & Evaluation

Bringing the rigour of an international evaluator to scientific strategy, regulatory pathways, and research assessment.

  • Scientific direction & regulatory strategy — incl. food supplement safety assessment for market placement
  • Research project & proposal evaluation
  • Publication strategy — acceptance rates, citation impact, experimental design
  • Doctoral & fellowship candidate assessment
Track record

Proof, not adjectives.

A consultancy is only as good as what it has actually delivered. A few examples.

EvaluationEuropean programmes
Our scientific director chaired the THCS 2nd Joint Transnational Call130 projects evaluated by a 38-member expert panel across a €34M+ budget — and serves as a registered evaluator for the European Commission, EFSA, EIT Health, Eurostars, and COST, among others.
OperationsUniversity of Oxford · IGC
Consolidated logistics and project management for senior researchers at the University of Oxford and the Instituto Gulbenkian de Ciência — integrating functions previously fragmented across four university departments into a single managed point, freeing researchers to focus on science and grant capture.
RegulatoryFood & supplements
Provide scientific direction for food supplement companies: translational activity studies and food safety assessments supporting market placement approval, plus publication strategy that improves acceptance rates and citation impact.
ProcessNational telecoms
Our managing partner's track record includes restructuring operations for 15,000 partners at Portugal's largest telecommunications operator, cutting complaint resolution from 90 days to 48 hours.
Principals

Who you'll work with.

Managing Partner

Miguel Galaz

M.A. International Relations · Executive MBA

Miguel leads operational and strategic engagements. Over thirteen years at Portugal's largest telecommunications operator he directed more than 150 projects in operations, process transformation, and customer experience; today he also advises the President of a Lisbon parish council on institutional reform. He holds a Master's in International Relations (IE, Madrid), a degree in Philosophy (University of Maryland), and an Executive MBA. Having spent much of his life abroad, he works fluently across cultures and institutions.

150+
Projects directed
13 yrs
National telecoms
3
Continents worked
LinkedIn ↗
Scientific Director & Managing Partner

Rosa Direito, Ph.D.

B.Sc. & M.Sc. Biochemistry · Ph.D. Pharmacy (Bromatology)

Rosa leads scientific consulting and evaluation. A researcher at iMed.ULisboa (Faculty of Pharmacy, Universidade de Lisboa) and university lecturer, she has authored 44 peer-reviewed publications — most in Q1 journals — and sits on the editorial board of Pharmaceutics. As an evaluator she has assessed research for the European Commission, EFSA, EIT Health, Eurostars, COST, the FAO, and national science agencies across Europe, and chaired a €34M+ transnational evaluation call. She brings that same rigour and scientific integrity to every engagement.

44
Publications
23
H-index
1,900+
Citations
200+
Projects evaluated
LinkedIn ↗
Contact

Start a conversation.

Tell us what you're trying to solve. If we're the right fit, we'll say so — and if we're not, we'll tell you that too.